REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 37 filers reported holding REDHILL BIOPHARMA LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $180,000 | -2.2% | 71,267 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $184,000 | -51.3% | 71,267 | -13.6% | 0.00% | -66.7% |
Q3 2021 | $378,000 | -33.5% | 82,523 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $568,000 | -10.8% | 82,523 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $637,000 | -3.9% | 82,523 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $663,000 | -21.4% | 82,523 | 0.0% | 0.01% | -37.5% |
Q3 2020 | $843,000 | +52.4% | 82,523 | 0.0% | 0.01% | +33.3% |
Q2 2020 | $553,000 | +30.4% | 82,523 | +15.8% | 0.01% | +20.0% |
Q1 2020 | $424,000 | -2.1% | 71,267 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $433,000 | -13.7% | 71,267 | 0.0% | 0.01% | -28.6% |
Q3 2019 | $502,000 | +8.9% | 71,267 | 0.0% | 0.01% | +16.7% |
Q2 2019 | $461,000 | -22.1% | 71,267 | 0.0% | 0.01% | -25.0% |
Q1 2019 | $592,000 | +49.9% | 71,267 | 0.0% | 0.01% | +33.3% |
Q4 2018 | $395,000 | -37.2% | 71,267 | 0.0% | 0.01% | -25.0% |
Q3 2018 | $629,000 | +3.5% | 71,267 | 0.0% | 0.01% | -20.0% |
Q2 2018 | $608,000 | +65.7% | 71,267 | 0.0% | 0.01% | +66.7% |
Q1 2018 | $367,000 | -0.3% | 71,267 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $368,000 | -52.2% | 71,267 | 0.0% | 0.01% | -53.8% |
Q3 2017 | $770,000 | +24.4% | 71,267 | 0.0% | 0.01% | +8.3% |
Q2 2017 | $619,000 | -9.4% | 71,267 | 0.0% | 0.01% | -7.7% |
Q1 2017 | $683,000 | -8.3% | 71,267 | 0.0% | 0.01% | -23.5% |
Q4 2016 | $745,000 | -24.9% | 71,267 | 0.0% | 0.02% | -29.2% |
Q3 2016 | $992,000 | +27.5% | 71,267 | 0.0% | 0.02% | +20.0% |
Q2 2016 | $778,000 | -10.4% | 71,267 | 0.0% | 0.02% | -9.1% |
Q1 2016 | $868,000 | -5.0% | 71,267 | 0.0% | 0.02% | -8.3% |
Q4 2015 | $914,000 | -0.7% | 71,267 | 0.0% | 0.02% | +4.3% |
Q3 2015 | $920,000 | -26.7% | 71,267 | 0.0% | 0.02% | -11.5% |
Q2 2015 | $1,255,000 | +21.1% | 71,267 | 0.0% | 0.03% | +23.8% |
Q1 2015 | $1,036,000 | +9.6% | 71,267 | 0.0% | 0.02% | +5.0% |
Q4 2014 | $945,000 | – | 71,267 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BANK HAPOALIM BM | 136,012 | $1,470,000 | 0.33% |
Family Management Corp | 37,750 | $408,000 | 0.28% |
MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $4,551,000 | 0.18% |
Migdal Insurance & Financial Holdings Ltd. | 397,410 | $4,296,000 | 0.10% |
Orbimed Advisors | 564,900 | $6,107,000 | 0.06% |
INGALLS & SNYDER LLC | 41,250 | $446,000 | 0.02% |
MONETARY MANAGEMENT GROUP INC | 3,000 | $32,000 | 0.01% |
Candriam S.C.A. | 71,267 | $770,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 10,870 | $118,000 | 0.01% |
D.A. DAVIDSON & CO. | 44,000 | $475,000 | 0.01% |